CLINICAL RELEVANCE OF EFFECT OF HEPATIC DISEASE ON DRUG DISPOSITION

被引:16
作者
BOND, WS
机构
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1978年 / 35卷 / 04期
关键词
D O I
10.1093/ajhp/35.4.406
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:406 / 414
页数:9
相关论文
共 70 条
[1]   KINETICS OF RIFAMPICIN AND ISONIAZID ADMINISTERED ALONE AND IN COMBINATION TO NORMAL SUBJECTS AND PATIENTS WITH LIVER-DISEASE [J].
ACOCELLA, G ;
BONOLLO, L ;
TENCONI, LT ;
GARIMOLDI, M ;
MAINARDI, M ;
NICOLIS, FB .
GUT, 1972, 13 (01) :47-+
[2]  
ALVIN J, 1975, J PHARMACOL EXP THER, V192, P224
[3]  
ANDERSON RJ, 1976, CLINICAL USE DRUGS R
[4]   PHARMACOKINETICS OF DIAZEPAM IN DISORDERED LIVER-FUNCTION [J].
ANDREASEN, PB ;
HENDEL, J ;
GREISEN, G ;
HVIDBERG, EF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (02) :115-120
[5]  
AVANT GR, 1975, DIGEST DIS, V20, P223
[6]  
AZZOLLINI F, 1972, INT J CLIN PHARM TH, V6, P130
[7]   SERUM IMMUNOSUPPRESSIVE ACTIVITY OF AZATHIOPRINE IN NORMAL SUBJECTS AND PATIENTS WITH LIVER-DISEASES [J].
BACH, JF ;
DARDENNE, M .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1972, 65 (03) :260-&
[8]  
BELLAMY HM, 1976, ANTIMICROB AGENTS CH, V6, P36
[9]  
BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO
[10]  
2-M